Untreated hepatitis C causes significant morbidity and mortality, including cirrhosis, liver cancer, and need for liver transplant. Yet current direct acting antivirals (DAAs) have cure rates between 95 and 100% for most patients, making it easier than ever for primary care providers to improve long-term outcomes for their patients with the condition. Approximately, 23,000 Mississippians are living with HCV.
The UMMC Project ECHO for Hepatitis C is a collaboration between Svenja Albrecht, MD, of UMMC and Centro San Vicente, a Federally Qualified Health Center in El Paso, TX. The goal is to make HCV treatment more accessible by patients within their own communities.
The hepatitis C ECHO meeting is hosted on the Zoom video conferencing platform monthly at 12:30 p.m. (CST). Providers will receive case submission links once they have registered as a participant.
To register for the next meeting, please email@example.com or Rudy.Castaneda@sanvicente.org
Svenja Albrecht, MD
Peyton Herrington, Pharm D
AMA category 1 CME credits are granted through the ECHO Institute at the University of New Mexico.
For more information, email firstname.lastname@example.org, or Rudy.Castaneda@sanvicente.org.